Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect-induced anaphylaxis shows unique features versus other indolent SM
- 1 February 2014
- journal article
- Published by Elsevier BV in Journal of Allergy and Clinical Immunology
- Vol. 133 (2), 520-528.e5
- https://doi.org/10.1016/j.jaci.2013.06.020
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Isolated bone marrow mastocytosis: an underestimated subvariant of indolent systemic mastocytosisHaematologica, 2010
- Clinical, Biological And Molecular Characteristics Of Mast Cell Activation Disorders: A Prospective Study In 62 Patients By The Spanish Network On Mastocytosis (REMA).Journal of Allergy and Clinical Immunology, 2009
- Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levelsJournal of Allergy and Clinical Immunology, 2009
- Standards and standardization in mastocytosis: Consensus Statements on Diagnostics, Treatment Recommendations and Response CriteriaEuropean Journal of Clinical Investigation, 2007
- KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders: a prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patientsBlood, 2006
- Diagnosis and classification of mast cell proliferative disorders: delineation from immunologic diseases and non–mast cell hematopoietic neoplasmsJournal of Allergy and Clinical Immunology, 2004
- Evidence for the involvement of a hematopoietic progenitor cell in systemic mastocytosis from single-cell analysis of mutations in the c-kit geneBlood, 2002
- Activating and dominant inactivating c-KITcatalytic domain mutations in distinct clinical forms of human mastocytosisProceedings of the National Academy of Sciences, 1999
- Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasmNature Genetics, 1996
- Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder.Proceedings of the National Academy of Sciences, 1995